Prophylaxis for Atrial fibrillation in PostCABG patients - PowerPoint PPT Presentation

1 / 26
About This Presentation
Title:

Prophylaxis for Atrial fibrillation in PostCABG patients

Description:

Prophylaxis for Atrial fibrillation in. Post-CABG patients. ???: ???. 2004/01/05. ICU reading ... Time to choose Amiodarone for postoperative atrial fibrillation? ... – PowerPoint PPT presentation

Number of Views:70
Avg rating:3.0/5.0
Slides: 27
Provided by: Lan955
Category:

less

Transcript and Presenter's Notes

Title: Prophylaxis for Atrial fibrillation in PostCABG patients


1
Prophylaxis for Atrial fibrillation in Post-CABG
patients
ICU reading
  • ??? ???
  • 2004/01/05

2
Post CABG Atrial fibrillation
  • Incidence 11-40
  • Consequences
  • Longer LOS ( 13.95 days 8.5 days)
  • Increase stroke incidence( 2.6 1.2)
  • potential morbidities throboembolic events, CHF,
    cardiogenic shock , coronary ischemia
  • J of clinical pharm and thera (2002)27,21-37

3
Prophylaxis agents
  • Beta-blocker standard
  • reduce hyperadrenergic state after CABG
  • Prevent withdrawal and rebound hypersensitivity
  • Sotalol
  • Magnesium sulfate
  • Amiodarone
  • Procainamide
  • Pacemaker
  • Digitalis,Verapamilno consistent benefit

4
ACC/AHA guidelines for CABG surgery 1475
5
Beta blocker
  • Meta-analysis of 19 beta-blocker trial Afib
    markly reduced (odds ratio 0.28)
  • Exclusion patients asthma, COPD, DM, CHF
  • common among patients undergoing cardiac surgery
    and limit the clinical utility of prophylaxis
    with beta-blockers

6
meta-analysis of antiarrhythmic therapy in the
prevention of postoperative Afib, LOS, costs,
CVA, and mortality
  • 13 randomized, controlled, double blind trials
    between Jan 1997 March 2001
  • 1783 patients enrolled
  • CABG1569 , valvular surgery87, both117, other
    10

AmerJCard Vol.91 May 1, 2003
7
Results incidence of post op AFib
8
Estimated effects of antiarrhythmic therapies on
hospital length of stay
9
Estimated effects of antiarrhythmic therapies of
hospital costs
10
meta-analysis of antiarrhythmic therapy in the
prevention of postoperative Afib, LOS, costs,
CVA, and mortality
  • Conclusion
  • Incidence Overall significant decrease of 0.52
    in the treatment group
  • Single tx decrease AF significantly/
    nonsignificantly
  • LOS overall 1.0/- 0.2 day decrease in (p lt
    0.001)
  • the incidence of stroke or mortality No
    significant effect
  • Disparate results in a single tx group

11
Amiodarone for prophylaxis of A fib
  • Several regimens
  • IV
  • oral
  • Pre-operative
  • Post-operative
  • IV Oral

12
IV Amiodarone
  • Hohnloser et al. placebo-controlled study of IV
    amiodarone (77 patients)
  • infusion began after the completion of the
    surgical procedure and significantly reduced the
    incidence of Afib( 5 21).
  • amiodarone was discontinued in 18 percent of
    patients because of side effects
  • Other studies bradycardia, cardiovascular
    instability

13
Oral Amiodarone Daoud et al
  • amiodarone 600 mg QD for seven days, then 200 mg
    QD until discharge
  • double-blind, randomized trial
  • 124 patients oral amiodarone (64 patients) or
    placebo (60 patients)
  • Mean (SD) pre-op total dose of Amiodarone
    4.8(0.96)g over a period of 13/-7days

NEJM Vol 337 num 25 1785-1791
14
Oral Amiodarone
  • reduced the incidence of Afib by 50
    percent(2553)
  • significantly reduced the LOS(1.4d) and total
    cost (8116)
  • reduced symptomatic episodes of Afib after
    discharge
  • not increase the risk of intraoperative or
    postoperative complications

15
Oral Amiodarone
  • not associated with proarrhythmia or serious
    adverse reactions
  • In pts with Afib reduced the ventricular rate
    significantly
  • Short-term low-dose oral amiodarone is not
    associated with the complications of intravenous
    administration
  • limitation the requirement of a seven-day
    preoperative treatment period.

16
Clinical pathway of oral Amiodarone prophylaxis
  • Pathway group Sep 1998Jan 1999(127)
  • Control group Jan 1998April 1998(102)

Amer J of Card Vol. 89 May 1 , 2002
17
Amer J of Card Vol. 89 May 1 , 2002
18
Oral Amiodarone prophylaxis
  • Elective Amiodarone 200 mg PO tid for 7 days,
    then 200 mg PO QD beginning immediately post op
    till discharge
  • Non-elective Amiodarone 600mg PO tid for 3 days,
    then 200mg PO QD beginning immediately post op
    till discharge

19
Results decrease of post op Afib
20
  • Result
  • Significant reduction in the incidence of post-op
    AF( 13.4 30.7)
  • Incidence of post-op AF, LOS and cost were
    similar for pathway patients stratified by pre-op
    or post op administration of Amiodarone.

21
  • Median post-op LOS 5 d 5 d
  • Median hospital costs 1.081.0( p0.006)
  • In Pt with post-op AFmedian LOS10d 6d
  • (p0.006)
  • Prolonged ventilator use( gt24hr) and reintubation
    in pathway group- increased incidence of of
    pneumonia (Only one case in pathway group may be
    due to Amiodarone pul toxicity)

22
Time to choose Amiodarone for postoperative
atrial fibrillation??
  • Q1 Is amiodarone more potent
  • Q2 Is Amiodarone more cost- effective

23
Q1 Is Amiodarone more potent
  • very little information currently available
  • meta-analysis of amiodarone versus sotalol no
    difference in the incidence of AF or , LOS, or
    adverse drug reaction between the drugs.
  • randomized trial of amiodarone against digoxin
    and metoprolol both regimens proved effective
    at reducing the incidence of AF. AF was less
    frequent in the amiodarone arm of this study (8
    vs 16), but insignificant
  • amiodarone against propanolol amiodarone was
    superior for preventing PAF, but not for length
    of stay.

J of Thorac and CArdiov Surg June 2003
24
Q2 Is Amiodarone cost- effective
  • even more poorly answered at this point
  • It has not yet been determined whether it is more
    potent or cost-effective than -blockers or other
    class III antiarrhythmic drugs already in use.

25
Time to choose Amiodarone for postoperative
atrial fibrillation??
  • standard prophylaxis for PAF now the routine
    administration of beta-blockers
  • Amiodarone reserved for blockade contraindicated
    or poorly tolerate the drug( poor ventricular
    function, congestive heart failure, severe lung
    disease, thyroid disease, allergy)
  • Selective patients high risk ??

26
  • Thank you for your attention!!
Write a Comment
User Comments (0)
About PowerShow.com